Galectin Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.3k | 5.6k | 1.66 |
| 2023-09-30 | $11k | 5.6k | 1.92 |
| 2023-06-30 | $8.1k | 5.6k | 1.44 |
| 2023-03-31 | $12k | 5.6k | 2.10 |
| 2022-12-31 | $6.7k | 5.9k | 1.13 |
| 2022-06-30 | $10k | 7.8k | 1.32 |
| 2021-12-31 | $16k | 6.6k | 2.40 |
| 2021-06-30 | $40k | 12k | 3.29 |
| 2021-03-31 | $103k | 48k | 2.15 |
| 2020-12-31 | $24k | 11k | 2.18 |
| 2020-09-30 | $20k | 7.5k | 2.69 |
| 2020-06-30 | $34k | 11k | 3.08 |
| 2020-03-31 | $9.4k | 4.4k | 2.13 |
| 2019-12-31 | $26k | 9.7k | 2.71 |
| 2019-09-30 | $41k | 11k | 3.66 |
| 2019-03-31 | $110k | 22k | 5.00 |
| 2018-12-31 | $13k | 4.4k | 3.00 |
| 2018-06-30 | $18k | 3.0k | 6.00 |
| 2018-03-31 | $41k | 8.3k | 5.00 |
| 2017-12-31 | $24k | 7.3k | 3.31 |
| 2017-09-30 | $16k | 7.6k | 2.10 |
| 2017-03-31 | $13k | 5.8k | 2.23 |
| 2016-12-31 | $9.8k | 9.3k | 1.05 |
| 2016-09-30 | $9.8k | 9.3k | 1.05 |
| 2016-06-30 | $14k | 9.8k | 1.40 |
| 2016-03-31 | $14k | 10k | 1.40 |
| 2015-12-31 | $28k | 10k | 2.72 |
| 2015-09-30 | $39k | 17k | 2.30 |
| 2015-06-30 | $47k | 18k | 2.69 |
| 2014-12-31 | $38k | 11k | 3.50 |
| 2014-09-30 | $84k | 17k | 5.04 |
| 2014-06-30 | $75k | 5.4k | 14.00 |
| 2014-03-31 | $107k | 7.1k | 15.20 |
| 2013-12-31 | $16k | 2.0k | 8.00 |
| 2012-12-31 | $998 | 531 | 1.88 |
| 2012-06-30 | $2.0k | 1.0k | 2.00 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation